Skip to main content
AAO-HNSF 2023 Annual Meeting & OTO Experience Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Rhinology/Allergy

Innovations in Office-Based Therapy of the Rhinology Patient

Tuesday, October 3, 2023
8:00 AM - 9:00 AM East Coast USA Time
Location: 102AB

    Moderator(s)

  • Kibwei A. McKinney, MD

    Associate Professor
    The University of Oklahoma Health Sciences Center
    Oklahoma City, OK, United States

    • Panelist(s)

  • PB

    Pete S. Batra, MD, FACS

    Stanton A. Friedberg, MD Endowed Chair, Professor and Chairman
    Rush University Medical Center
    Chicago, IL, United States

  • RM

    R. Peter Manes, MD

    Associate Professor
    Yale School of Medicine
    New Haven, CT, United States

  • MC

    Martin J. Citardi, MD

    Department Chair and Vice Dean
    McGovern Medical School (UTHealth Houston)
    Bellaire, TX, United States

Disclosure(s):
Kibwei A. McKinney, MD: No relevant relationships to disclose.
Pete S. Batra, MD, FACS: No relevant relationships to disclose.
Martin J. Citardi, MD: No relevant relationships to disclose.
PROGRAM DESCRIPTION: Since the advent of balloon sinus dilation, there has been a proliferation of office-based techniques utilized in the treatment of diseases that affect the nose and paranasal sinuses. In order for these technological advances to be successful, they must be appropriately applied based on disease- and patient-specific factors. This first part of this session will focus on the selection of patients and the pre-authorization process that is required to ensure reimbursement. This will include a discussion of how to counsel patients in preparation for the planned procedure. The session will then address the various anesthetic methods used in the awake patient in order to ensure patient comfort, including the administration of systemic and topical agents. Technical advances in nasal obstruction, including subcutaneous stenting and radiofrequency ablation of the nasal valve, will then be reviewed. This will consist of technical descriptions of these procedures and a discussion of the expected outcomes and potential complications. Non-resorbing steroid-eluting implants have recently gained favor in the long-term management of chronic rhinosinusitis with nasal polyposis. The session will conclude with a review of the data and a case-based discussion of these adjuvant therapies and address the maintenance issues that may arise while they are in place.

OUTCOME OBJECTIVE 1: To master the pre-authorization process for office-based procedures, including balloon sinus dilation, nasal obstruction techniques, drug-eluting stent placement, and vidian nerve cryo-ablation.

OUTCOME OBJECTIVE 2: To implement a local anesthetic protocol that may be used to facilitate the successful execution of office-based procedures in the awake patient.

OUTCOME OBJECTIVE 3: To gain mastery of novel techniques used to treat nasal obstruction in the awake patient while minimizing patient discomfort and understand the role of drug eluting stents in the care of CRS with nasal polyps.

BACKGROUND STATEMENT: With the recent expansion of office-based rhinologic technologies, there is a need for an in-depth discussion of patient-selection, pre-authorization, and technique-specific nuances of these procedures.